Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16735 | 639 | 35.0 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
56 | 2 | MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA | 29625 |
16735 | 1 | EVI1//EVI 1//RIZ1 | 639 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EVI1 | authKW | 2775331 | 10% | 88% | 66 |
2 | EVI 1 | authKW | 1359208 | 5% | 89% | 32 |
3 | RIZ1 | authKW | 780477 | 3% | 78% | 21 |
4 | PR DOMAIN | authKW | 538373 | 2% | 87% | 13 |
5 | 3Q21Q26 SYNDROME | authKW | 525634 | 2% | 100% | 11 |
6 | MDS1 EVI1 | authKW | 382279 | 1% | 100% | 8 |
7 | MECOM | authKW | 322544 | 1% | 75% | 9 |
8 | RIZ | authKW | 305820 | 1% | 80% | 8 |
9 | MDS1 | authKW | 286709 | 1% | 100% | 6 |
10 | PROGRAM ONCOGENES TUMOR SUPP SOR GENES | address | 254847 | 1% | 67% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 6447 | 31% | 0% | 197 |
2 | Oncology | 5317 | 47% | 0% | 302 |
3 | Genetics & Heredity | 2526 | 27% | 0% | 171 |
4 | Cell Biology | 694 | 18% | 0% | 117 |
5 | Biochemistry & Molecular Biology | 318 | 22% | 0% | 141 |
6 | Developmental Biology | 62 | 2% | 0% | 15 |
7 | Pathology | 41 | 3% | 0% | 19 |
8 | Cell & Tissue Engineering | 11 | 0% | 0% | 3 |
9 | Medical Laboratory Technology | 11 | 1% | 0% | 6 |
10 | Biophysics | 7 | 2% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROGRAM ONCOGENES TUMOR SUPP SOR GENES | 254847 | 1% | 67% | 8 |
2 | BIOCHEM 332 N LAUDERDALE | 117064 | 1% | 35% | 7 |
3 | LUDWIG BOLTZMANN LEUKAEMIEFOR HAEMATOL | 95570 | 0% | 100% | 2 |
4 | TUMOR CELLULAR BIOCHEM | 68855 | 1% | 21% | 7 |
5 | CORE IL FLOW CYTOMETRY SURG S | 63712 | 0% | 67% | 2 |
6 | ADV SHOWA KU | 47785 | 0% | 100% | 1 |
7 | ALFA COORDINAT | 47785 | 0% | 100% | 1 |
8 | ARCISPEDALE STANNA | 47785 | 0% | 100% | 1 |
9 | BEHAVIORAL DEV DISORDERS | 47785 | 0% | 100% | 1 |
10 | BIONET INC | 47785 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER GENETICS AND CYTOGENETICS | 31110 | 10% | 1% | 63 |
2 | LEUKEMIA | 6864 | 5% | 0% | 33 |
3 | GENES CHROMOSOMES & CANCER | 4864 | 3% | 1% | 18 |
4 | ONCOGENE | 3392 | 6% | 0% | 36 |
5 | BRITISH JOURNAL OF HAEMATOLOGY | 2365 | 4% | 0% | 26 |
6 | BLOOD | 1860 | 6% | 0% | 37 |
7 | CANCER GENETICS | 1843 | 1% | 1% | 4 |
8 | LEUKEMIA RESEARCH | 1120 | 2% | 0% | 12 |
9 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 1012 | 1% | 0% | 9 |
10 | CANCER SCIENCE | 653 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EVI1 | 2775331 | 10% | 88% | 66 | Search EVI1 | Search EVI1 |
2 | EVI 1 | 1359208 | 5% | 89% | 32 | Search EVI+1 | Search EVI+1 |
3 | RIZ1 | 780477 | 3% | 78% | 21 | Search RIZ1 | Search RIZ1 |
4 | PR DOMAIN | 538373 | 2% | 87% | 13 | Search PR+DOMAIN | Search PR+DOMAIN |
5 | 3Q21Q26 SYNDROME | 525634 | 2% | 100% | 11 | Search 3Q21Q26+SYNDROME | Search 3Q21Q26+SYNDROME |
6 | MDS1 EVI1 | 382279 | 1% | 100% | 8 | Search MDS1+EVI1 | Search MDS1+EVI1 |
7 | MECOM | 322544 | 1% | 75% | 9 | Search MECOM | Search MECOM |
8 | RIZ | 305820 | 1% | 80% | 8 | Search RIZ | Search RIZ |
9 | MDS1 | 286709 | 1% | 100% | 6 | Search MDS1 | Search MDS1 |
10 | PRDM14 | 227673 | 1% | 53% | 9 | Search PRDM14 | Search PRDM14 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WIESER, R , (2007) THE ONCOGENE AND DEVELOPMENTAL REGULATOR EVI1: EXPRESSION, BIOCHEMICAL PROPERTIES, AND BIOLOGICAL FUNCTIONS.GENE. VOL. 396. ISSUE 2. P. 346-357 | 81 | 87% | 67 |
2 | WANG, HY , RASHIDI, HH , (2016) THE NEW CLINICOPATHOLOGIC AND MOLECULAR FINDINGS IN MYELOID NEOPLASMS WITH INV(3)(Q21Q26)/T(3;3)(Q21;Q26.2).ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. VOL. 140. ISSUE 12. P. 1404 -1410 | 55 | 100% | 0 |
3 | GLASS, C , WILSON, M , GONZALEZ, R , ZHANG, Y , PERKINS, AS , (2014) THE ROLE OF EVI1 IN MYELOID MALIGNANCIES.BLOOD CELLS MOLECULES AND DISEASES. VOL. 53. ISSUE 1-2. P. 67-76 | 57 | 79% | 11 |
4 | DE BRAEKELEER, M , LE BRIS, MJ , DE BRAEKELEER, E , BASINKO, A , MOREL, F , DOUET-GUILBERT, N , (2015) 3Q26/EVI1 REARRANGEMENTS IN MYELOID HEMOPATHIES: A CYTOGENETIC REVIEW.FUTURE ONCOLOGY. VOL. 11. ISSUE 11. P. 1675 -1686 | 56 | 81% | 1 |
5 | YUAN, XF , WANG, XD , BI, KH , JIANG, GS , (2015) THE ROLE OF EVI-1 IN NORMAL HEMATOPOIESIS AND MYELOID MALIGNANCIES (REVIEW).INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 47. ISSUE 6. P. 2028 -2036 | 51 | 82% | 0 |
6 | GOYAMA, S , KUROKAWA, M , (2009) PATHOGENETIC SIGNIFICANCE OF ECOTROPIC VIRAL INTEGRATION SITE-1 IN HEMATOLOGICAL MALIGNANCIES.CANCER SCIENCE. VOL. 100. ISSUE 6. P. 990 -995 | 51 | 89% | 20 |
7 | FOG, CK , GALLI, GG , LUND, AH , (2012) PRDM PROTEINS: IMPORTANT PLAYERS IN DIFFERENTIATION AND DISEASE.BIOESSAYS. VOL. 34. ISSUE 1. P. 50-60 | 64 | 54% | 59 |
8 | HELLER, G , ROMMER, A , STEINLEITNER, K , ETZLER, J , HACKL, H , HEFFETER, P , TOMASICH, E , FILIPITS, M , STEINMETZ, B , TOPAKIAN, T , ET AL (2015) EVI1 PROMOTES TUMOR GROWTH VIA TRANSCRIPTIONAL REPRESSION OF MS4A3.JOURNAL OF HEMATOLOGY & ONCOLOGY. VOL. 8. ISSUE . P. - | 54 | 70% | 3 |
9 | HINAI, AA , VALK, PJM , (2016) REVIEW: ABERRANT EVI1 EXPRESSION IN ACUTE MYELOID LEUKAEMIA.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 172. ISSUE 6. P. 870 -878 | 48 | 76% | 0 |
10 | MZOUGHI, S , TAN, YX , LOW, D , GUCCIONE, E , (2016) THE ROLE OF PRDMS IN CANCER: ONE FAMILY, TWO SIDES.CURRENT OPINION IN GENETICS & DEVELOPMENT. VOL. 36. ISSUE . P. 83 -91 | 46 | 70% | 1 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 4828 | RUNX3//AML1 ETO//RUNX1 |
2 | 16606 | PRDM1//BLIMP 1//PLASMA CELLS |
3 | 14203 | GATA 1//GATA2//EDAG |
4 | 3631 | PHILADELPHIA CHROMOSOME//CANCER GENETICS AND CYTOGENETICS//BCR ABL |
5 | 29445 | ZNF217//CTBP//CTBP1 |
6 | 3781 | MYELODYSPLASTIC SYNDROME//CANCER GENETICS AND CYTOGENETICS//MYELODYSPLASIA |
7 | 7627 | TEL AML1//TEL//ETV6 |
8 | 17423 | JUVENILE MYELOMONOCYTIC LEUKEMIA//JMML//JUVENILE MYELOMONOCYTIC LEUKAEMIA |
9 | 8127 | SECONDARY LEUKEMIA//THERAPY RELATED//THERAPY RELATED LEUKEMIA |
10 | 5973 | MLL//MLL GENE//11Q23 |